JA PCM
@japcm.bsky.social
Strengthens the personalised cancer medicine network across Europe
Reposted by JA PCM
🚀 We took part in the kick-off meeting of the @japcm.bsky.social: a new EU initiative to expand access to personalised cancer care across Europe.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
January 21, 2026 at 6:02 PM
🚀 We took part in the kick-off meeting of the @japcm.bsky.social: a new EU initiative to expand access to personalised cancer care across Europe.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
🔬 As partners, VHIO lead a pilot to create a supranational Molecular Tumor Board for rare and complex cases and work on harmonising data collection.
We’re excited to kick off the Joint Action on Personalised Cancer Medicine (JA PCM) today in Brussels 🎉
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
January 14, 2026 at 9:44 AM
We’re excited to kick off the Joint Action on Personalised Cancer Medicine (JA PCM) today in Brussels 🎉
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.
Funded by #EU4Health, 146 organisations from 29 European countries are joining forces to advance personalised cancer care across the full patient pathway, from prevention to follow-up.